These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35284395)

  • 1. Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia.
    Chang SL; Cliff OM; Zachreson C; Prokopenko M
    Front Public Health; 2022; 10():823043. PubMed ID: 35284395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitigating the SARS-CoV-2 Delta disease burden in Australia by non-pharmaceutical interventions and vaccinating children: a modelling analysis.
    Milne GJ; Carrivick J; Whyatt D
    BMC Med; 2022 Feb; 20(1):80. PubMed ID: 35177062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of re-opening the international border on COVID-19 hospitalisations in Australia: a modelling study.
    Hanly MJ; Churches T; Fitzgerald O; Post JJ; MacIntyre CR; Jorm L
    Med J Aust; 2022 Jan; 216(1):39-42. PubMed ID: 34633100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical timing and extent of public health interventions to control outbreaks dominated by SARS-CoV-2 variants in Australia: a mathematical modelling study.
    Zou Z; Fairley CK; Shen M; Scott N; Xu X; Li Z; Li R; Zhuang G; Zhang L
    Int J Infect Dis; 2022 Feb; 115():154-165. PubMed ID: 34800688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in the control of COVID-19 outbreaks caused by the delta variant during periods of low humidity: an observational study in Sydney, Australia.
    Ward MP; Liu Y; Xiao S; Zhang Z
    Infect Dis Poverty; 2021 Dec; 10(1):139. PubMed ID: 34937575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pens down: An outbreak of the B.1.617.2 SARS-CoV-2 variant in an Australian high school, August 2021.
    Allen K; Marmor A; Pourmarzi D
    Commun Dis Intell (2018); 2022 Jul; 46():. PubMed ID: 35860870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Containment of SARS-CoV-2 Delta strain in Guangzhou, China by quarantine and social distancing: a modelling study.
    Zeng Z; Wu T; Lin Z; Luo L; Lin Z; Guan W; Liang J; Yu M; Guan P; He W; Liu Z; Lu G; Xie P; Chen C; Lau EHY; Yang Z; Hon C; He J
    Sci Rep; 2022 Dec; 12(1):21096. PubMed ID: 36473881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of sustained SARS-CoV-2 transmission in Queensland, Australia.
    Sanz-Leon P; Stevenson NJ; Stuart RM; Abeysuriya RG; Pang JC; Lambert SB; Kerr CC; Roberts JA
    Sci Rep; 2022 Apr; 12(1):6309. PubMed ID: 35428853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
    Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H;
    Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating local outbreak risks and the effects of non-pharmaceutical interventions in age-structured populations: SARS-CoV-2 as a case study.
    Lovell-Read FA; Shen S; Thompson RN
    J Theor Biol; 2022 Feb; 535():110983. PubMed ID: 34915042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding SARS-CoV-2 Delta and Omicron variant transmission and vaccine impact in schools and child-care settings in Australia: a population-based study.
    Koirala A; Winkler NE; Quinn HE; Gardiner E; Liu B; Forbes J; Sharpe C; van Tussenbroek T; Wood N; Macartney K
    Lancet Reg Health West Pac; 2023 Jun; 35():100736. PubMed ID: 37360872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19, Australia: Epidemiology Report 19 (Fortnightly reporting period ending 21 June 2020).
    COVID-19 National Incident Room Surveillance Team
    Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32600222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a real-world network to model the trade-off between stay-at-home restriction, vaccination, social distancing and working hours on COVID-19 dynamics.
    Nashebi R; Sari M; Kotil S
    PeerJ; 2022; 10():e14353. PubMed ID: 36540805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine breakthrough infections in a highly-vaccinated Australian population during a SARS-CoV-2 Delta outbreak.
    Sheel M; Vun Voo T; Pingault N; Sloan-Gardner TS; Marmor A; Kirk MD; Johnston V; Coleman K
    Commun Dis Intell (2018); 2022 Jun; 46():. PubMed ID: 35739073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Discrete-Event, Simulated Social Agent-Based Network Transmission (DESSABNeT) model for communicable diseases: Method and validation using SARS-CoV-2 data in three large Australian cities.
    Stapelberg NJC; Smoll NR; Randall M; Palipana D; Bui B; Macartney K; Khandaker G; Wattiaux A
    PLoS One; 2021; 16(5):e0251737. PubMed ID: 34019561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated Transmission Outcomes and Costs of SARS-CoV-2 Diagnostic Testing, Screening, and Surveillance Strategies Among a Simulated Population of Primary School Students.
    Bilinski A; Ciaranello A; Fitzpatrick MC; Giardina J; Shah M; Salomon JA; Kendall EA
    JAMA Pediatr; 2022 Jul; 176(7):679-689. PubMed ID: 35442396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policy Interventions, Social Distancing, and SARS-CoV-2 Transmission in the United States: A Retrospective State-level Analysis.
    Dreher N; Spiera Z; McAuley FM; Kuohn L; Durbin JR; Marayati NF; Ali M; Li AY; Hannah TC; Gometz A; Kostman JT; Choudhri TF
    Am J Med Sci; 2021 May; 361(5):575-584. PubMed ID: 33775425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating measures to reduce the transmission of SARS-CoV-2 in Australia to guide a 'National Plan' to reopening.
    Ryan GE; Shearer FM; McCaw JM; McVernon J; Golding N
    Epidemics; 2024 Jun; 47():100763. PubMed ID: 38513465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lives saved by public health restrictions over the Victorian COVID-19 Delta variant epidemic wave, Aug-Nov 2021.
    Delport D; Sacks-Davis R; Abeysuriya RG; Hellard M; Scott N
    Epidemics; 2023 Sep; 44():100702. PubMed ID: 37327657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.